CN104758935B - 一种改善复方布洛芬制剂稳定性的组合物及其制备方法 - Google Patents
一种改善复方布洛芬制剂稳定性的组合物及其制备方法 Download PDFInfo
- Publication number
- CN104758935B CN104758935B CN201510167620.9A CN201510167620A CN104758935B CN 104758935 B CN104758935 B CN 104758935B CN 201510167620 A CN201510167620 A CN 201510167620A CN 104758935 B CN104758935 B CN 104758935B
- Authority
- CN
- China
- Prior art keywords
- composition
- parts
- weight
- preparation
- iuprofen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510167620.9A CN104758935B (zh) | 2015-04-10 | 2015-04-10 | 一种改善复方布洛芬制剂稳定性的组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510167620.9A CN104758935B (zh) | 2015-04-10 | 2015-04-10 | 一种改善复方布洛芬制剂稳定性的组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104758935A CN104758935A (zh) | 2015-07-08 |
CN104758935B true CN104758935B (zh) | 2017-11-21 |
Family
ID=53641245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510167620.9A Expired - Fee Related CN104758935B (zh) | 2015-04-10 | 2015-04-10 | 一种改善复方布洛芬制剂稳定性的组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104758935B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107929272A (zh) * | 2016-10-13 | 2018-04-20 | 长春海悦药业股份有限公司 | 一种布洛肾素片剂组合物及其制备方法 |
CN107929247A (zh) * | 2016-10-13 | 2018-04-20 | 长春海悦药业股份有限公司 | 一种布洛肾素那敏片剂组合物及其制备方法 |
CN111208246B (zh) * | 2019-12-29 | 2022-11-01 | 中国大冢制药有限公司 | 一种萘敏维滴眼液有关物质的检测方法 |
CN112472677A (zh) * | 2020-11-12 | 2021-03-12 | 澳美制药厂有限公司 | 肾素那敏制剂及其制备方法 |
CN113876731B (zh) * | 2021-10-29 | 2023-10-13 | 山东则正医药技术有限公司 | 一种含布洛肾素那敏的药物组合物及制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI313598B (en) * | 2002-12-18 | 2009-08-21 | Wyeth Corp | Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines |
-
2015
- 2015-04-10 CN CN201510167620.9A patent/CN104758935B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN104758935A (zh) | 2015-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104758935B (zh) | 一种改善复方布洛芬制剂稳定性的组合物及其制备方法 | |
JP5255429B2 (ja) | リン酸オセルタミビル含有医薬組成物 | |
CN103687591A (zh) | 包含蒙特鲁卡斯特及左旋西替利的胶囊调配物 | |
CN114288257B (zh) | 一种马来酸氟伏沙明片剂及其制备方法 | |
CN108478595A (zh) | 一种含有碳酸钙、维生素d3、维生素k2的药物组合物 | |
JP5173431B2 (ja) | 無水ラクトース凝集物およびその製造 | |
JP7469304B2 (ja) | Parpインヒビタを含む医薬組成物 | |
US20120214820A1 (en) | Orally disintegrating pharmaceutical dosage form containing aripiprazole | |
CN101278914A (zh) | 头孢泊肟酯干混悬剂组合物及其制备方法 | |
Wollmer et al. | A biopredictive In vitro approach for assessing compatibility of a novel pediatric hydrocortisone drug product within common pediatric dosing vehicles | |
WO2014101115A1 (zh) | 一种孟鲁司特钠片组合物及其制备方法 | |
CN112933061B (zh) | 一种盐酸阿比多尔胶囊及其制备方法 | |
TW201609194A (zh) | 含有托格列淨(Tofogliflozin)之固體製劑及其製造方法 | |
CN104523631B (zh) | 一种治疗抑郁症的奥氮平口腔崩解片的制备方法 | |
CN104840427B (zh) | 一种含有孟鲁司特钠的药物组合物 | |
WO2019004449A1 (ja) | 医薬組成物 | |
CN108066312A (zh) | 一种帕博西尼药物组合物及其制备方法 | |
CN108553433A (zh) | 一种阿齐沙坦片及其制备方法 | |
CN107929247A (zh) | 一种布洛肾素那敏片剂组合物及其制备方法 | |
JP2007186450A (ja) | 塩酸パロキセチン含有製剤およびその製造方法 | |
JP4462476B2 (ja) | 混合顆粒剤の製造方法 | |
CN102058602A (zh) | 一种稳定的含氯沙坦钾和氢氯噻嗪的口服固体制剂 | |
CN105769800B (zh) | 一种盐酸沙格雷酯片及其制备方法 | |
CN113133977B (zh) | 一种马来酸阿法替尼片及其制备方法 | |
CN114028348B (zh) | 一种枸橼酸西地那非口腔崩解片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190829 Address after: 430000 Hubei Province Wuhan Hongshan District Donghu New Technology Development Zone Laowu-Huanghe Highway 206 Huigu Space-time Building 705, 706A Patentee after: He Yonggang Address before: Room 1045, Dongfangyang Building, 129-2 Binhai Avenue, Haikou City, Hainan Province, 570311 Patentee before: Haikou Shi Kang Remedy Research Limited |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191205 Address after: 200135 No. 778, Chuangxin West Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Patentee after: PGM clinical research (Shanghai) Co., Ltd Address before: 430000 Hubei Province Wuhan Hongshan District Donghu New Technology Development Zone Laowu-Huanghe Highway 206 Huigu Space-time Building 705, 706A Patentee before: He Yonggang |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171121 Termination date: 20210410 |